300119.SZ
瑞普生物
SZSE · Healthcare · C 制造业 · CN
CNY 17.34
−3.24%Aug 31, 2026, 11:08 UTC
Ruipu Biology announced that two avian influenza vaccines passed the Ministry of Agriculture and Rural Affairs' review for production strain change filing.
Source:Aug 25, 2026, 09:32 UTC
Ruipu Biology announced it will continue an asset pool business with Zhejiang Shang Bank Tianjin Branch totaling up to 100 million yuan, with mutual guarantees among subsidiaries, valid for one year.
Source:Aug 25, 2026, 09:31 UTC
Ruipu Biology announced its 2026 first-half results: net profit attributable to shareholders was 204 million yuan, down 20.43% year-on-year, with revenue of 1.72 billion yuan, up 0.75%.
Source: